In insulin resistance and endothelial dysfunction, a hyperactivity of the renin-angiotensin-aldosterone system (RAAS) plays a crucial role, and therefore targeting it on a different molecular level benefits in improvement in insulin sensitivity and vascular function. The gene discussed is INS; the disease is endothelial dysfunction.